Sector
Radiopharma Executive Search & Recruitment
The radiopharmaceutical sector is undergoing a structural transformation as the industry pivots from beta emitters to targeted alpha therapies. The operating constraints are shifting from molecule design to manufacturing physics, isotope supply-chain architecture, dual NRC/FDA regulatory compliance, and a severe scarcity of radiation-qualified leadership talent. ProGen Search is a specialist radiopharma executive search firm operating across this ecosystem, placing senior leaders into radiopharmaceutical developers, radiopharma CDMOs, isotope suppliers, radiopharmacy networks, and the institutional investors backing them.
Coverage
What Our Radiopharma Recruitment Covers
Executive search and market intelligence across targeted radionuclide therapy (RLT), alpha and beta emitter platforms (Ac-225, Pb-212, At-211, Lu-177), isotope production and supply chain, GMP hot-cell manufacturing and radiochemistry, radiopharmacy network operations, nuclear regulatory compliance (NRC, HPRA, BfS), clinical dosimetry and medical physics, and commercial launch readiness for radioligand therapies.
Leadership
Radiopharma Leadership Roles We Place
Track Record
Related Mandates
Radiopharmaceutical Manufacturing (USA)
Chief Operating Officer
Built GMP capacity and strengthened isotope supply resilience
Radiopharmaceutical Biotech (USA)
SVP Regulatory Affairs
Strengthened FDA engagement and advanced global regulatory readiness
Radiopharma Manufacturer (USA)
Facility Expansion Project
Scaled infrastructure for new isotope production line
If you are hiring leadership talent in radiopharmaceuticals, book a confidential call to discuss your requirements.
Book a Confidential Call